Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Gottschlich

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancers|February 3, 2021
Therapeutic Strategies for Targeting IL-1 in CancerAdrian Gottschlich, Stefan Endres, Sebastian Kobold
Translational Lung Cancer Research|May 22, 2018
Can we use interleukin-1β blockade for lung cancer treatment?Adrian Gottschlich, Stefan Endres, Sebastian Kobold
Deutsche Medizinische Wochenschrift (1946)|January 20, 2026
[Flow cytometry in hematological diagnostics - step by step]Adrian Gottschlich, Marion Subklewe, Veit Bücklein
Memo|November 15, 2021
CAR T cell therapy in solid tumors: a short reviewÖykü Umut, Adrian Gottschlich, Stefan Endres, et al.
Current Opinion in Pharmacology|May 1, 2025
Novel approaches to CAR T cell target identification in acute myeloid leukemiaGordon Victor Hoffmann, Adrian Gottschlich, Marion Subklewe, et al.
Biological Chemistry|May 20, 2024
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapiesChristina Angeliki Tsiverioti, Adrian Gottschlich, Marcel Trefny, et al.
Computers in Biology and Medicine|May 16, 2025
The role of single cell transcriptomics for efficacy and toxicity profiling of chimeric antigen receptor (CAR) T cell therapiesMoritz Thomas, Ruben Brabenec, Lisa Gregor, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 8, 2024
Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis SetsStefani Xhaxho, Linping Chen-Wichmann, Sophie Kreissig, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Interleukin-37 monomer is the active form for reducing innate immunityElan Z Eisenmesser, Adrian Gottschlich, Jasmina S Redzic, et al.
Current Oncology (Toronto, Ont.)|January 20, 2022
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid TumorsJulian Kolorz, Salih Demir, Adrian Gottschlich, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancers|February 3, 2021
Therapeutic Strategies for Targeting IL-1 in CancerAdrian Gottschlich, Stefan Endres, Sebastian Kobold
Translational Lung Cancer Research|May 22, 2018
Can we use interleukin-1β blockade for lung cancer treatment?Adrian Gottschlich, Stefan Endres, Sebastian Kobold
Deutsche Medizinische Wochenschrift (1946)|January 20, 2026
[Flow cytometry in hematological diagnostics - step by step]Adrian Gottschlich, Marion Subklewe, Veit Bücklein
Memo|November 15, 2021
CAR T cell therapy in solid tumors: a short reviewÖykü Umut, Adrian Gottschlich, Stefan Endres, et al.
Current Opinion in Pharmacology|May 1, 2025
Novel approaches to CAR T cell target identification in acute myeloid leukemiaGordon Victor Hoffmann, Adrian Gottschlich, Marion Subklewe, et al.
Biological Chemistry|May 20, 2024
Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapiesChristina Angeliki Tsiverioti, Adrian Gottschlich, Marcel Trefny, et al.
Computers in Biology and Medicine|May 16, 2025
The role of single cell transcriptomics for efficacy and toxicity profiling of chimeric antigen receptor (CAR) T cell therapiesMoritz Thomas, Ruben Brabenec, Lisa Gregor, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|April 8, 2024
Efficient Chimeric Antigen Receptor T-Cell Generation Starting with Leukoreduction System Chambers of Thrombocyte Apheresis SetsStefani Xhaxho, Linping Chen-Wichmann, Sophie Kreissig, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 2, 2019
Interleukin-37 monomer is the active form for reducing innate immunityElan Z Eisenmesser, Adrian Gottschlich, Jasmina S Redzic, et al.
Current Oncology (Toronto, Ont.)|January 20, 2022
The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid TumorsJulian Kolorz, Salih Demir, Adrian Gottschlich, et al.
Pageof 4